Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Arzneimittelforschung ; 45(10): 1133-7, 1995 Oct.
Article in English | MEDLINE | ID: mdl-8595076

ABSTRACT

SDZ 62-434 (CAS 115621-95-9, 5-(4'-piperidinomethylphenyl)-2,3-dihydroimidazo [2,1-a]isoquinoline dihydrochloride), a member of a novel class of antitumor agents, exhibited direct and macrophage-induced cytotoxicity against a variety of murine tumor cell lines. It is more effective than edelfosine in increasing survivors and reducing tumor volume in the oral mouse Meth A fibrosarcoma model. Preliminary studies suggest that an undefined cytotoxic effect, macrophage activation and possible effects on signal transduction may account for its antitumor mechanism of action. SDZ 62-434 is currently in Phase I clinical trials as a potential antitumor agent.


Subject(s)
Antineoplastic Agents/pharmacology , Imidazoles/pharmacology , Isoquinolines/pharmacology , Allantoin/metabolism , Animals , Antineoplastic Agents/toxicity , Bronchodilator Agents/pharmacology , Cell Survival/drug effects , Chick Embryo , Dogs , Drug Screening Assays, Antitumor , Fibroblasts/drug effects , Fibroblasts/metabolism , Guinea Pigs , Hemodynamics/drug effects , Hemolysis/drug effects , Humans , Imidazoles/toxicity , In Vitro Techniques , Isoquinolines/toxicity , Macrophage Activation/drug effects , Male , Mice , Mice, Inbred Strains , Neoplasm Transplantation , Platelet Aggregation/drug effects , Rats , Rats, Sprague-Dawley , Signal Transduction/drug effects , Tumor Cells, Cultured
2.
Arzneimittelforschung ; 44(12): 1384-8, 1994 Dec.
Article in English | MEDLINE | ID: mdl-7848363

ABSTRACT

A piperidine phospholipid ((+/-)-2-[hydroxy] [1-octadecyloxycarbonylpiperidin-3-yl]methoxy-phosphinyl] oxy]-N,N,N, trimethylethaniminium hydroxide inner salt, SDZ 62-826) has been prepared that exhibited weak direct cytotoxicity and strong macrophage-induced cytotoxicity in vitro against a variety of murine and one human tumor cell lines. This compound was found to be as effective as ET-18-OCH3 and SRI 62-834, phospholipids with both strong direct and macrophage-induced cytotoxicity, in increasing survivors and reducing tumor volume when given either orally or intravenously in the mouse MethA fibrosarcoma model. These findings suggest that the macrophage-induced cytotoxicity exhibited by ET-18-OCH3 and other phospholipids may play an important role in this tumor model.


Subject(s)
Antineoplastic Agents/pharmacology , Phospholipid Ethers/pharmacology , Piperidines/pharmacology , Receptors, Cell Surface , Receptors, G-Protein-Coupled , Animals , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/therapeutic use , Binding, Competitive/drug effects , Cell Survival/drug effects , Fibroblasts/drug effects , Fibrosarcoma/drug therapy , Humans , Lethal Dose 50 , Macrophages/drug effects , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Neoplasm Transplantation , Phospholipid Ethers/chemical synthesis , Phospholipid Ethers/therapeutic use , Piperidines/chemical synthesis , Piperidines/therapeutic use , Platelet Activating Factor/metabolism , Platelet Aggregation Inhibitors/pharmacology , Platelet Membrane Glycoproteins/drug effects , Receptors, Platelet-Derived Growth Factor/drug effects , Sarcoma, Experimental/drug therapy , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...